OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 61 filers reported holding OVID THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $310 | -17.6% | 80,800 | -29.6% | 0.00% | 0.0% |
Q2 2023 | $376 | +20.9% | 114,700 | -4.9% | 0.00% | – |
Q1 2023 | $311 | +39.5% | 120,600 | +0.7% | 0.00% | – |
Q4 2022 | $223 | -99.9% | 119,800 | +0.8% | 0.00% | – |
Q3 2022 | $219,000 | -17.7% | 118,800 | -4.0% | 0.00% | – |
Q2 2022 | $266,000 | 0.0% | 123,800 | +46.0% | 0.00% | – |
Q1 2022 | $266,000 | +41.5% | 84,800 | +44.7% | 0.00% | – |
Q4 2021 | $188,000 | +62.1% | 58,600 | +69.9% | 0.00% | – |
Q3 2021 | $116,000 | -92.9% | 34,500 | -95.1% | 0.00% | -100.0% |
Q4 2020 | $1,641,000 | -64.3% | 710,507 | +13.8% | 0.00% | -50.0% |
Q2 2020 | $4,600,000 | +81.0% | 624,109 | -26.8% | 0.00% | +100.0% |
Q1 2020 | $2,541,000 | -43.6% | 852,843 | -21.4% | 0.00% | -33.3% |
Q4 2019 | $4,502,000 | +136.8% | 1,084,709 | +84.9% | 0.00% | +50.0% |
Q3 2019 | $1,901,000 | +118.0% | 586,725 | +24.4% | 0.00% | +100.0% |
Q2 2019 | $872,000 | +35.6% | 471,609 | +29.8% | 0.00% | 0.0% |
Q1 2019 | $643,000 | +383.5% | 363,217 | +559.2% | 0.00% | – |
Q4 2018 | $133,000 | – | 55,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |